abcsg.research Publications 2013
The EndoPredict score provides prognostic information on late distant metastases in ERþ/HER2 breast cancer patients
Dubsky P, Brase J C, Jakesz R, Rudas M, Singer C F, Greil R, Dietze O, Luisser I, Klug E, Sedivy R, Bachner M, Mayr D, Schmidt M, Gehrmann M C, Petry C, Weber K E, Fisch K, Kronenwett R, Gnant M, Filipits M on behalf of the Austrian Breast and Colorectal Cancer
British Journal of Cancer (2013)
Advance online publication 24 October 2013
Differential survival trends of stage II colorectal cancer patients relate to promoter methylation status of PCDH10, SPARC, and UCHL1
Heitzer E, Artl M, Filipits M, Resel M, Graf R, Weißenbacher B, Lax S, Gnant M, Wrba F, Greil R, Dietze O, Hofbauer F, Böhm G, Höfler G, Samonigg H, Schaberl-Moser R, Balic M and Dandachi N
Modern Pathology 1-10, 2013.
EndoPredict improves the prognostic classification derived from common clinical guidelines in ER-positive, HER2-negative early breast cancer
Dubsky P, Filipits M, Jakesz R, Rudas M, Singer CF, Greil R, Dietze O, Luisser I, Klug E, Sedivy R, Bachner M, Mayr D, Schmidt M, Gehrmann MC, Petry C, Weber KE, Kronenwett R, Brase JC, Gnant M on behalf of the Austrian Breast and Colorectal Cancer Study Group (ABCSG)..
Ann Oncol 24, 640-647, 2013.
Cytochrome P450 2D6 poor metabolizer phenotype is associated with worse outcomes in women receiving tamoxifen: results from the Austrian Breast and Colorectal Study 8
Goetz MP, Suman VJ, Ames MM, Gnant M, Filipits M, Hoskin TL, Safgren SL, Kuffel M, Jakesz R, Rudas M, Greil R, Dietze O, Lang A, Offner F, Reynolds CA, Weinshilboum RM, Ingle JN.
Clin Cancer Res 107, 1978-1986, 2013.